581 related articles for article (PubMed ID: 31758946)
1. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
Öztürk AA; Kıyan HT
Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
[TBL] [Abstract][Full Text] [Related]
2. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
3. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
4. Ketorolac Tromethamine Loaded Nano-Spray Dried Nanoparticles: Preparation, Characterization, Cell Viability, COL1A1 Gene Simulation and Determination of Anti-inflammatory Activity by
Öztürk AA; Çevikelli T; Tilki EK; Güven UM; Kıyan HT
Curr Drug Deliv; 2023; 20(6):830-840. PubMed ID: 36698231
[TBL] [Abstract][Full Text] [Related]
5. Development of Orally Applicable, Combinatorial Drug-Loaded Nanoparticles for the Treatment of Fibrosarcoma.
Demirbolat GM; Altintas L; Yilmaz S; Degim IT
J Pharm Sci; 2018 May; 107(5):1398-1407. PubMed ID: 29339136
[TBL] [Abstract][Full Text] [Related]
6. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
7. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
Sweed NM; Basalious EB; Nour SA
Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
9. Dexketoprofen trometamol: clinical evidence supporting its role as a painkiller.
Rodríguez MJ; Arbós RM; Amaro SR
Expert Rev Neurother; 2008 Nov; 8(11):1625-40. PubMed ID: 18986233
[TBL] [Abstract][Full Text] [Related]
10. A Novel Phytotherapy Application: Preparation, Characterization, Antioxidant Activities and Determination of Anti-inflammatory Effects by
Ismailovi N; Kıyan HT; Öztürk AA
Curr Drug Deliv; 2024; 21(6):901-916. PubMed ID: 37018530
[TBL] [Abstract][Full Text] [Related]
11. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
[TBL] [Abstract][Full Text] [Related]
12. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
13. Preclinical and clinical development of dexketoprofen.
Mauleón D; Artigas R; García ML; Carganico G
Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
[TBL] [Abstract][Full Text] [Related]
14. Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles.
Hanafy AF; Abdalla AM; Guda TK; Gabr KE; Royall PG; Alqurshi A
Int J Nanomedicine; 2019; 14():3679-3689. PubMed ID: 31239660
[No Abstract] [Full Text] [Related]
15. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
17. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress.
Yu Z; Ma L; Ye S; Li G; Zhang M
Carbohydr Polym; 2020 May; 236():115972. PubMed ID: 32172827
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]